RFK Jr Draws Parallels Between Fauci’s Handling of the AIDS CRisis and the COVID Pandemic

During an interview with Megyn Kelly, Robert F. Kennedy Jr. outlined a damning critique of Dr. Anthony Fauci's early career, drawing a direct parallel between his handling of the AIDS crisis and the COVID-19 pandemic. The central accusation? A pattern of aligning with a single, profitable pharmaceutical product while suppressing other potential treatments.

Kennedy detailed the story of the drug AZT. Originally developed as a chemotherapy drug by the National Cancer Institute, it was deemed so horrendously toxic that it was discarded and never even patented. When the AIDS epidemic emerged, the company Burroughs Wellcome (now GlaxoSmithKline) discovered it could kill the HIV virus in a petri dish.

This is where, according to Kennedy, Fauci’s pivotal role began. After successfully arguing that AIDS was an infectious disease under his agency's purview (NIAID) and not a cancer, Fauci—unexperienced in drug development—became dependent on the pharmaceutical industry. He allegedly stacked committees with company loyalists to rush AZT through, shutting out all competition.

The most shocking claim? That during clinical trials, AZT was killing so many patients that investigators began giving them life-saving blood transfusions to keep them alive long enough to complete the study. This artificial life-support, Kennedy asserts, masked the drug's extreme toxicity and was used to justify its approval.

The result, critics estimate, was 330,000 deaths over the following decade from a drug once deemed too toxic for short-term chemotherapy.

The parallel to COVID is clear: a narrative of fealty to a single, lucrative solution—first a toxic drug, then a vaccine—at the expense of broader, safer treatment options. The story of AZT, as presented by RFK Jr., isn't just history; it's a blueprint for understanding the present.